LILRB1 and renal cell carcinoma: HLA-G, which binds to CD85j with higher affinity than the classical MHC-I (35), is expressed in RCC cells (36, 37) and plays an inhibitory role on NK cell-mediated cytotoxicity against tumor cells (37).